1. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004; 72(1): 29-39.
2. Sommer I, Ramsey N, Kahn R, Aleman A, Bouma A. Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. Br J Psychiatry 2001; 178: 344-51.
3. Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord 2007; 9(1-2): 93-102.
4. Dias VV, Balanza-Martinez V, Soeiro-de-Souza MG, Moreno RA, Figueira ML, Machado-Vieira R, et al. Pharmacological approaches in bipolar disorders and the impact on cognition: A critical overview. Acta Psychiatr Scand 2012; 126(5): 315-31.
5. Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, et al. The MATRICS Consensus Cognitive Battery, part 2: Co-norming and standardization. Am J Psychiatry 2008; 165(2): 214-20.
6. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. The MATRICS Consensus Cognitive Battery, part 1: Test selection, reliability, and validity. Am J Psychiatry 2008; 165(2): 203-13.
7. Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998; 20(3): 310-9.
8. Woodcock RW, McGrew KS, Mather N. Woodcock-Johnson III tests of cognitive abilities.Itasca, IL: Riverside; 2001.
9. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004; 68(2-3): 283-97.
10. Purdon SE. The Screen for Cognitive Impairment in Psychiatry (SCIP): Instructions and three alternative forms. Edmonton, AB: PNL Inc.; 2005.
11. Gomez-Benito J, Guilera G, Pino O, Rojo E, Tabares-Seisdedos R, Safont G, et al. The screen for cognitive impairment in psychiatry: Diagnostic-specific standardization in psychiatric ill patients. BMC Psychiatry 2013; 13: 127.
12. Pino O, Guilera G, Gomez J, Rojo JE, Vellejo J, Purdon SE. A brief scale to assess cognitive impairment in psychiatric patients. Psicothema 2006; 18(3): 447-52. [In Spanish].
13. Pino O, Guilera G, Rojo JE, Gomez-Benito J, Bernardo M, Crespo-Facorro B, et al. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia. Schizophr Res 2008; 99(1-3): 139-48.
14. Guilera G, Pino O, Gomez-Benito J, Rojo JE, Vieta E, Tabares-Seisdedos R, et al. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder. Health Qual Life Outcomes 2009; 7: 28.
15. Gomez-Benito J, Guilera G, Pino O, Tabares-Seisdedos R, Martinez-Aran A. Comparing neurocognitive impairment in schizophrenia and bipolar I disorder using the Screen for Cognitive Impairment in Psychiatry Scale. Int J Clin Health Psychol 2014; 14(2): 128-36.
16. Rojo E, Pino O, Guilera G, Gomez-Benito J, Purdon SE, Crespo-Facorro B, et al. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S). Schizophr Res 2010; 116(2-3): 243-51.
17. Vieta E, Gasto C, Otero A, Nieto E, Vallejo J. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 1997; 38(2): 98-101.
18. Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN, et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186: 32-40.
19. Torrent C, Martinez-Aran A, Daban C, Sanchez-Moreno J, Comes M, Goikolea JM, et al. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006; 189: 254-9.